Gliclazide
未知生产厂商
Gliclazide is a sulfonylurea used to treat hyperglycemia in patients with type 2 diabetes mellitus.
Gliclazide is a sulfonylurea used to treat hyperglycemia in patients with type 2 diabetes mellitus.
Gliclazide binds to the β cell sulfonyl urea receptor (SUR1). This binding subsequently blocks the ATP sensitive potassium channels. The binding results in closure of the channels and leads to a resulting decrease in potassium efflux leads to depolarization of the β cells. This opens voltage-dependent calcium channels in the β cell resulting in calmodulin activation, which in turn leads to exocytosis of insulin containing secretorty granules.
For the treatment of NIDDM in conjunction with diet and exercise.
共 1 项相关疾病
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。